Back to Trades
Torti Frank
President and Vant ChairCIK 0001647805
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 3
- Companies
- 2
- Active
- 2025–2026
Across 7 filings between 2025–2026, Torti Frank, President and Vant Chair, has disclosed $118.6M in transactions — spread across 2 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $82.0M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Jul 2 | ROIV Roivant Sciences Ltd. | Torti Frank | President and Vant Chair | Tax withheld | $1.4M |
| Apr 9 | IMVT Immunovant, Inc. | Torti Frank | Director | Grant | $2.2M |
| Apr 2 | ROIV Roivant Sciences Ltd. | Torti Frank | President and Vant Chair | Tax withheld | $4.4M |
| Feb 23 | ROIV Roivant Sciences Ltd. | Torti Frank | President and Vant Chair | Sell | $82.0M |
| Dec 29 | ROIV Roivant Sciences Ltd. | Torti Frank | Insider | Grant | $3.9M |
| Aug 1 | ROIV Roivant Sciences Ltd. | Torti Frank | Insider | Grant | $0 |
| Jul 29 | ROIV Roivant Sciences Ltd. | Torti Frank | Insider | Other | $0 |
7 filings